Gene Therapy Flops for Critical Limb Ischemia – MedPage Today
MedPage Today |
Gene Therapy Flops for Critical Limb Ischemia
MedPage Today ORLANDO — A novel gene therapy treatment for critical limb ischemia — the non-viral DNA plasmid-based therapy encoding for stromal cell-derived factor-1, dubbed JVS-100 — did not improve wound healing when added to revascularization, researchers … |
